Advances in the Study of Pluripotent Stem Cells in Livestock

Abstract

Livestock pluripotent stem cells, derived either from early embryos or induced through somatic cell reprogramming technology, possess the unique ability to self-renew, maintain an undifferentiated state and differentiate into various cell types. Consequently, the generation of PSCs from agricultural animal species holds great potential for applications in livestock breed improvement, rapid propagation, disease modelling and xenotransplantation. However, compared to the great achievements made in mouse and human pluripotent stem cells research, the generation of livestock pluripotent stem cells still remains challenging. This article offers an overview of the classification, regulatory mechanisms of pluripotency, and developmental history of livestock pluripotent stem cells, while also anticipating their future application prospects. These insights provide valuable references for the reproduction and breeding of large livestock.

Keywords

application prospects / embryonic stem cells / induced pluripotent stem cells / livestock

References

[1] N. Amin, X. Tan, Q. Ren, et al., “Recent Advances of Induced Pluripotent Stem Cells Application in Neurodegenerative Diseases,” Progress in Neuro-Psychopharmacology & Biological Psychiatry 95 (2019): 109674.

[2] D. Kumar, T. R. Talluri, N. L. Selokar, et al., “Perspectives of Pluripotent Stem Cells in Livestock,” World Journal of Stem Cells 13, no. 1 (2021): 1-29.

[3] M. Kinoshita, M. Barber, W. Mansfield, et al., “Capture of Mouse and Human Stem Cells with Features of Formative Pluripotency,” Cell Stem Cell 28, no. 3 (2021): 453-471.

[4] N. Christodoulou, C. Kyprianou, A. Weberling, et al., “Sequential Formation and Resolution of Multiple Rosettes Drive Embryo Remodelling After Implantation,” Nature Cell Biology 20, no. 11 (2018): 1278-1289.

[5] T. Kobayashi, H. Zhang, W. Tang, et al., “Principles of Early Human Development and Germ Cell Program From Conserved Model Systems,” Nature 546, no. 7658 (2017): 416-420.

[6] S. Yamanaka, “Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges,” Cell Stem Cell 27, no. 4 (2020): 523-531.

[7] S. Soderholm and C. Cantu, “The WNT/Beta-Catenin Dependent Transcription: A Tissue-Specific Business,” WIREs Mechanisms of Disease 13, no. 3 (2021): e1511.

[8] F. Aulicino, E. Pedone, F. Sottile, et al., “Canonical Wnt Pathway Controls mESC Self-Renewal Through Inhibition of Spontaneous Differentiation via beta-Catenin/TCF/LEF Functions,” Stem Cell Reports 15, no. 3 (2020): 646-661.

[9] R. Abdalkader, R. Chaleckis, and T. Fujita, “Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics Analysis,” Metabolites 13, no. 6 (2023): 706, https://doi.org/10.3390/metabo13060706.

[10] H. Osada, M. Kawatou, D. Fujita, et al., “Therapeutic Potential of Clinical-Grade Human Induced Pluripotent Stem Cell-Derived Cardiac Tissues,” JTCVS Open 8 (2021): 359-374.

[11] T. Xu, P. Su, L. Wu, et al., “OCT4 Regulates WNT/Beta-Catenin Signaling and Prevents Mesoendoderm Differentiation by Repressing EOMES in Porcine Pluripotent Stem Cells,” Journal of Cellular Physiology 238, no. 12 (2023): 2855-2866.

[12] C. Xue, Q. Yao, X. Gu, et al., “Evolving Cognition of the JAK-STAT Signaling Pathway: Autoimmune Disorders and Cancer,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 204.

[13] G. Chen, S. Yin, H. Zeng, et al., “Regulation of Embryonic Stem Cell Self-Renewal,” Life (Basel) 12, no. 8 (2022): 1151, https://doi.org/10.3390/life12081151.

[14] P. Y. Bourillot, C. Santamaria, L. David, et al., “GP130 Signaling and the Control of Naive Pluripotency in Humans, Monkeys, and Pigs,” Experimental Cell Research 386, no. 1 (2020): 111712.

[15] M. Mossahebi-Mohammadi, M. Quan, J. S. Zhang, et al., “FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency,” Frontiers in Cell and Developmental Biology 8 (2020): 79.

[16] W. B. Hamilton, Y. Mosesson, R. S. Monteiro, et al., “Dynamic Lineage Priming Is Driven via Direct Enhancer Regulation by ERK,” Nature 575, no. 7782 (2019): 355-360.

[17] C. S. Simon, S. Rahman, D. Raina, et al., “Live Visualization of ERK Activity in the Mouse Blastocyst Reveals Lineage-Specific Signaling Dynamics,” Developmental Cell 55, no. 3 (2020): 341-353.

[18] S. Bessonnard, S. Coqueran, S. Vandormael-Pournin, et al., “ICM Conversion to Epiblast by FGF/ERK Inhibition Is Limited in Time and Requires Transcription and Protein Degradation,” Scientific Reports 7, no. 1 (2017): 12285.

[19] K. Hayes, Y. K. Kim, and M. F. Pera, “A Case for Revisiting Nodal Signaling in Human Pluripotent Stem Cells,” Stem Cells 39, no. 9 (2021): 1137-1144.

[20] X. Wang, C. Song, Y. Ye, et al., “BRD9-Mediated Control of the TGF-Beta/Activin/Nodal Pathway Regulates Self-Renewal and Differentiation of Human Embryonic Stem Cells and Progression of Cancer Cells,” Nucleic Acids Research 51, no. 21 (2023): 11634-11651.

[21] S. Pauklin and L. Vallier, “Activin/Nodal Signalling in Stem Cells,” Development 142, no. 4 (2015): 607-619.

[22] Z. Ai, B. Niu, K. Duan, et al., “Modulation of Wnt and Activin/Nodal Supports Efficient Derivation, Cloning and Suspension Expansion of Human Pluripotent Stem Cells,” Biomaterials 249 (2020): 120015.

[23] F. Zhang, C. Pang, H. Zhu, et al., “Timely Stimulation of Early Embryo Promotes the Acquisition of Pluripotency,” Cytometry. Part A 101, no. 8 (2022): 682-691.

[24] K. Takahashi and S. Yamanaka, “Induction of Pluripotent Stem Cells From Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors,” Cell 126, no. 4 (2006): 663-676.

[25] R. Blelloch, M. Venere, J. Yen, et al., “Generation of Induced Pluripotent Stem Cells in the Absence of Drug Selection,” Cell Stem Cell 1, no. 3 (2007): 245-247.

[26] L. Wang, Y. Su, C. Huang, et al., “NANOG and LIN28 Dramatically Improve Human Cell Reprogramming by Modulating LIN41 and Canonical WNT Activities,” Biology Open 8, no. 12 (2019): bio047225, https://doi.org/10.1242/bio.047225.

[27] J. Yu, M. A. Vodyanik, K. Smuga-Otto, et al., “Induced Pluripotent Stem Cell Lines Derived From Human Somatic Cells,” Science 318, no. 5858 (2007): 1917-1920.

[28] F. Anokye-Danso, C. M. Trivedi, D. Juhr, et al., “Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency,” Cell Stem Cell 8, no. 4 (2011): 376-388.

[29] G. Guo and A. Smith, “A Genome-Wide Screen in EpiSCs Identifies Nr5a Nuclear Receptors as Potent Inducers of Ground State Pluripotency,” Development 137, no. 19 (2010): 3185-3192.

[30] M. J. Evans and M. H. Kaufman, “Establishment in Culture of Pluripotential Cells From Mouse Embryos,” Nature 292, no. 5819 (1981): 154-156.

[31] X. Gao, M. Nowak-Imialek, X. Chen, et al., “Establishment of Porcine and Human Expanded Potential Stem Cells,” Nature Cell Biology 21, no. 6 (2019): 687-699.

[32] L. Zhao, X. Gao, Y. Zheng, et al., “Establishment of Bovine Expanded Potential Stem Cells,” Proceedings of the National Academy of Sciences of the United States of America 118, no. 15 (2021): e2018505118, https://doi.org/10.1073/pnas.2018505118.

[33] Q. Zhu, F. Wang, D. Gao, et al., “Generation of Stable Integration-Free Pig Induced Pluripotent Stem Cells Under Chemically Defined Culture Condition,” Cell Proliferation 56, no. 11 (2023): e13487.

[34] J. K. Lunney, A. Van Goor, K. E. Walker, et al., “Importance of the Pig as a Human Biomedical Model,” Science Translational Medicine 13, no. 621 (2021): eabd5758.

[35] J. Yang, D. J. Ryan, W. Wang, et al., “Establishment of Mouse Expanded Potential Stem Cells,” Nature 550, no. 7676 (2017): 393-397.

[36] M. Zhi, J. Zhang, Q. Tang, et al., “Generation and Characterization of Stable Pig Pregastrulation Epiblast Stem Cell Lines,” Cell Research 32, no. 4 (2022): 383-400.

[37] L. Wang, E. Duan, L. Y. Sung, et al., “Generation and Characterization of Pluripotent Stem Cells From Cloned Bovine Embryos,” Biology of Reproduction 73, no. 1 (2005): 149-155.

[38] X. Wu, M. Song, X. Yang, et al., “Establishment of Bovine Embryonic Stem Cells After Knockdown of CDX2,” Scientific Reports 6 (2016): 28343.

[39] Y. S. Bogliotti, J. Wu, M. Vilarino, et al., “Efficient Derivation of Stable Primed Pluripotent Embryonic Stem Cells From Bovine Blastocysts,” Proceedings of the National Academy of Sciences of the United States of America 115, no. 9 (2018): 2090-2095.

[40] D. A. Soto, M. Navarro, C. Zheng, et al., “Simplification of Culture Conditions and Feeder-Free Expansion of Bovine Embryonic Stem Cells,” Scientific Reports 11, no. 1 (2021): 11045.

[41] S. S. Pawar, D. Malakar, A. K. De, et al., “Stem Cell-Like Outgrowths From In Vitro Fertilized Goat Blastocysts,” Indian Journal of Experimental Biology 47, no. 8 (2009): 635-642.

[42] D. A. Kumar, D. Malakar, Y. S. Akshey, et al., “Isolation and Characterization of Embryonic Stem Cell-Like Cells From In Vitro Produced Goat (Capra hircus) Embryos,” Animal Biotechnology 22, no. 4 (2011): 181-196.

[43] M. Vilarino, S. D. Alba, B. Y. Soledad, et al., “Derivation of Sheep Embryonic Stem Cells Under Optimized Conditions,” Reproduction 160, no. 5 (2020): 761-772.

[44] T. Ezashi, B. P. Telugu, A. P. Alexenko, et al., “Derivation of Induced Pluripotent Stem Cells From Pig Somatic Cells,” Proceedings of the National Academy of Sciences of the United States of America 106, no. 27 (2009): 10993-10998.

[45] Q. Gu, J. Hao, T. Hai, et al., “Efficient Generation of Mouse ESCs-Like Pig Induced Pluripotent Stem Cells,” Protein & Cell 5, no. 5 (2014): 338-342.

[46] X. Han, J. Han, F. Ding, et al., “Generation of Induced Pluripotent Stem Cells From Bovine Embryonic Fibroblast Cells,” Cell Research 21, no. 10 (2011): 1509-1512.

[47] T. R. Talluri, D. Kumar, S. Glage, et al., “Derivation and Characterization of Bovine Induced Pluripotent Stem Cells by Transposon-Mediated Reprogramming,” Cellular Reprogramming 17, no. 2 (2015): 131-140.

[48] L. Zhao, Z. Wang, J. Zhang, et al., “Characterization of the Single-Cell Derived Bovine Induced Pluripotent Stem Cells,” Tissue & Cell 49, no. 5 (2017): 521-527.

[49] Y. Jiang, N. N. Cai, X. L. An, et al., “Naive-Like Conversion of Bovine Induced Pluripotent Stem Cells From Sertoli Cells,” Theriogenology 196 (2023): 68-78.

[50] L. Bao, L. He, J. Chen, et al., “Reprogramming of Ovine Adult Fibroblasts to Pluripotency via Drug-Inducible Expression of Defined Factors,” Cell Research 21, no. 4 (2011): 600-608.

[51] J. Liu, D. Balehosur, B. Murray, et al., “Generation and Characterization of Reprogrammed Sheep Induced Pluripotent Stem Cells,” Theriogenology 77, no. 2 (2012): 338-346.

[52] C. Sartori, A. I. DiDomenico, A. J. Thomson, et al., “Ovine-Induced Pluripotent Stem Cells Can Contribute to Chimeric Lambs,” Cellular Reprogramming 14, no. 1 (2012): 8-19.

[53] Y. Zhang, Y. He, P. Wu, et al., “miR-200c-141 Enhances Sheep Kidney Cell Reprogramming into Pluripotent Cells by Targeting ZEB1,” International Journal of Stem Cells 14, no. 4 (2021): 423-433.

[54] M. Liu, L. Zhao, Z. Wang, et al., “Generation of Sheep Induced Pluripotent Stem Cells With Defined DOX-Inducible Transcription Factors via piggyBac Transposition,” Frontiers in Cell and Developmental Biology 9 (2021): 785055.

[55] K. Hayashi, S. Ogushi, K. Kurimoto, et al., “Offspring From Oocytes Derived From In Vitro Primordial Germ Cell-Like Cells in Mice,” Science 338, no. 6109 (2012): 971-975.

[56] D. E. Goszczynski, H. Cheng, S. Demyda-Peyras, et al., “In Vitro Breeding: Application of Embryonic Stem Cells to Animal Production,” Biology of Reproduction 100, no. 4 (2019): 885-895.

[57] J. Li, J. Chi, Y. Yang, et al., “PHDs-seq: A Large-Scale Phenotypic Screening Method for Drug Discovery Through Parallel Multi-Readout Quantification,” Cell Regeneration 12, no. 1 (2023): 22.

[58] G. Yang and X. Huang, “Methods and Applications of CRISPR/Cas System for Genome Editing in Stem Cells,” Cell Regeneration 8, no. 2 (2019): 33-41.

[59] B. P. Griffith, C. E. Goerlich, A. K. Singh, et al., “Genetically Modified Porcine-to-Human Cardiac Xenotransplantation,” New England Journal of Medicine 387, no. 1 (2022): 35-44.

[60] Y. Yue, W. Xu, Y. Kan, et al., “Extensive Germline Genome Engineering in Pigs,” Nature Biomedical Engineering 5, no. 2 (2021): 134-143.

[61] J. Wang, W. Xie, N. Li, et al., “Generation of a Humanized Mesonephros in Pigs From Induced Pluripotent Stem Cells via Embryo Complementation,” Cell Stem Cell 30, no. 9 (2023): 1235-1245.

[62] J. T. Neal, X. Li, J. Zhu, et al., “Organoid Modeling of the Tumor Immune Microenvironment,” Cell 175, no. 7 (2018): 1972-1988.

[63] T. Sato, R. G. Vries, H. J. Snippert, et al., “Single Lgr5 Stem Cells Build Crypt-Villus Structures In Vitro Without a Mesenchymal Niche,” Nature 459, no. 7244 (2009): 262-265.

[64] M. Qu, L. Xiong, Y. Lyu, et al., “Establishment of Intestinal Organoid Cultures Modeling Injury-Associated Epithelial Regeneration,” Cell Research 31, no. 3 (2021): 259-271.

[65] S. U. Hwang, K. Eun, M. Kim, et al., “Establishment of 3D Neuro-Organoids Derived From Pig Embryonic Stem-Like Cells,” International Journal of Molecular Sciences 22, no. 5 (2021): 2600, https://doi.org/10.3390/ijms22052600.

[66] H. Derricott, L. Luu, W. Y. Fong, et al., “Developing a 3D Intestinal Epithelium Model for Livestock Species,” Cell and Tissue Research 375, no. 2 (2019): 409-424.

[67] N. Yang, L. Chen, W. Wang, et al., “The Land Carrying Capacity and Environmental Risk Assessment of Livestock and Poultry Breeding Considering Crop Planting,” Environmental Science and Pollution Research International 28, no. 37 (2021): 51356-51368.

[68] S. S. Nielsen, J. Alvarez, D. J. Bicout, et al., “Welfare of Cattle at Slaughter,” EFSA Journal 18, no. 11 (2020): e06275.

[69] K. D. Fish, N. R. Rubio, A. J. Stout, et al., “Prospects and Challenges for Cell-Cultured Fat as a Novel Food Ingredient,” Trends in Food Science and Technology 98 (2020): 53-67.

[70] N. Xiang, J. J. Yuen, A. J. Stout, et al., “3D Porous Scaffolds From Wheat Glutenin for Cultured Meat Applications,” Biomaterials 285 (2022): 121543.

[71] C. Bomkamp, S. C. Skaalure, G. F. Fernando, et al., “Scaffolding Biomaterials for 3D Cultivated Meat: Prospects and Challenges,” Advanced Science (Weinh) 9, no. 3 (2022): e2102908.

[72] E. Xu, R. Niu, J. Lao, et al., “Tissue-Like Cultured Fish Fillets Through a Synthetic Food Pipeline,” npj Science of Food 7, no. 1 (2023): 17.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.